INGRAM ROBERT ALEXANDER 4
4 · Black Diamond Therapeutics, Inc. · Filed Jun 22, 2021
Insider Transaction Report
Form 4
INGRAM ROBERT ALEXANDER
Director
Transactions
- Award
Common Stock
2021-06-18$12.95/sh+1,255$16,252→ 7,437 total - Award
Stock Option (Right to Buy)
2021-06-18+15,000→ 15,000 totalExercise: $12.55Exp: 2031-06-17→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]These shares were issued in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 17, 2021.
- [F3]This option shall vest and become exercisable in full upon the earlier to occur of (i) June 18, 2022 or (ii) the next annual meeting of the Issuer's stockholders.